(Q40771766)

23 September 2017

Anti-HIV activity of a novel aminoglycoside-arginine conjugate (English)

1 reference

23 September 2017

4

1 reference

23 September 2017

Bonaventura Clotet Sala

7

object named as

Bonaventura Clotet

1 reference

23 September 2017

Jordi Barretina Ginesta

3

object named as

Jordi Barretina

1 reference

23 September 2017

Cecilia Cabrera

1

1 reference

23 September 2017

Arantxa Gutiérrez

2

1 reference

23 September 2017

Alexander Litovchick

5

1 reference

23 September 2017

Aviva Lapidot

6

1 reference

23 September 2017

José A Esté

8

1 reference

23 September 2017

1 January 2002

1 reference

23 September 2017

1 reference

23 September 2017

53

1 reference

23 September 2017

1

1 reference

23 September 2017

1-8

1 reference

Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Inhibition of HIV type 1 Tat-mediated trans-activation by oncostatin M in HLtat cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Infection of human tonsil histocultures: a model for HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Aminoglycoside-arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900188-7

7 January 2021

10.1016/S0166-3542(01)00188-7

Identifiers

DOI

1 reference

23 September 2017

1 reference